Barclays PLC Accuray Inc Call Options Transaction History

Barclays PLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$3.54 - $4.64 $58,056 - $76,096	-16,400 Reduced 98.2%	300 $1,000
Q1 2019 May 15, 2019	BUY	$3.32 - $5.28 $33,200 - $52,800	10,000 Added 149.25%	16,700 $80,000
Q4 2018 Feb 14, 2019	SELL	$3.31 - $5.24 $41,044 - $64,976	-12,400 Reduced 64.92%	6,700 $23,000
Q3 2018 Nov 14, 2018	BUY	$3.48 - $4.6 $56,376 - $74,520	16,200 Added 558.62%	19,100 $86,000
Q2 2018 Aug 14, 2018	SELL	$3.85 - $5.15 $16,555 - $22,145	-4,300 Reduced 59.72%	2,900 $12,000
Q1 2018 May 15, 2018	SELL	$4.5 - $5.9 $15,300 - $20,060	-3,400 Reduced 32.08%	7,200 $36,000
Q4 2017 Feb 14, 2018	BUY	$3.95 - $5.3 $24,095 - $32,330	6,100 Added 135.56%	10,600 $46,000
Q3 2017 Nov 14, 2017	BUY	$3.9 - $4.6 $17,550 - $20,700	4,500	4,500 $18,000

141

55.7M

68.6K

12.8K

Ticker ARAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 93,579,696
Market Cap $209M
Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.